FDA commissioner with experience akin to drug advisory cmte. chair suggested by NDMA.
This article was originally published in The Tan Sheet
Executive Summary
FDA COMMISSIONER SEARCH: DRUG ADVISORY CMTE. CHAIR EXPERIENCE cited by the Nonprescription Drug Manufacturers Association as a desirable qualification for the future FDA head. In a Feb. 4 letter to HHS Secretary Donna Shalala, NDMA recommends that the new commissioner have "a recognized expertise in managing sensitive medical and scientific issues, as might be found in a person who had served as chairman to a drug advisory committee." Among the names that have been circulated as a possible successor to retiring FDA Commissioner David Kessler, MD, is former Nonprescription Drugs Advisory Committee Chair Randy Juhl, PhD, dean of the University of Pittsburgh School of Pharmacy ("The Tan Sheet" Dec. 9, 1996, p. 11).
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning